StockData
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

CEL SCI CORP

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.65−0.14 (-7.82%)

Close on Oct 19, 2026

Market cap
$19.99M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Cel Sci has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Cel Sci filed with the SEC